25 phenotypes from 5 alleles in 7 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Il9em1(IMPC)Mbp/Il9em1(IMPC)Mbp C57BL/6NCrl-Il9em1(IMPC)Mbp/MbpMmucd	abnormal kidney morphology	J:211773
	abnormal liver morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal testis morphology	J:211773
	abnormal uterus morphology	J:211773
	abnormal vitreous body morphology	J:211773
	cataract	J:211773
	enlarged spleen	J:211773
	enlarged testis	J:211773
	increased circulating alanine transaminase level	J:211773
	small kidney	J:211773
	small liver	J:211773
Il9tm1Anjm/Il9tm1Anjm involves: 129P2/OlaHsd * C57BL/6	abnormal enzyme/coenzyme activity	J:82881
	abnormal intestinal goblet cell morphology	J:82881
	abnormal mast cell morphology	J:82881
	abnormal response to infection	J:82881
	granulomatous inflammation	J:82881, J:113543
	increased susceptibility to parasitic infection	J:82881
Il9tm1Anjm/Il9tm1Anjm involves: C57BL/6	abnormal cytokine secretion	J:115764
	normal immune system phenotype	J:115764
Il9tm1Flv/Il9tm1Flv BALB/c-Il9tm1Flv	increased susceptibility to parasitic infection	J:208730
Il9tm2.1Flv/Il9+ C.B6N(FVB)-Il9tm2.1Flv	no abnormal phenotype detected	J:208730
Tg(Pim1-Il9)5Jcrd/0 involves: BALB/c * FVB/N	increased susceptibility to type I hypersensitivity reaction	J:100568
Tg(Pim1-Il9)5Jcrd/0 involves: FVB/N	increased incidence of tumors by chemical induction	J:17848
	increased interleukin-5 secretion	J:115764
	increased susceptibility to type I hypersensitivity reaction	J:100568
	increased T cell derived lymphoma incidence	J:17848